May 2025 - Page 2 of 2

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

By Mourabit Halima 2025.05.14

At ESCMID Global 2025, Infectious Disease Frontier interviewed Dr. Francesco Cogliati Dezza to explore the renewed clinical relevance of temocillin. With resistance to broad-spectrum antibiotics on the rise, temocillin is…

Professor Li Zhang’s Team Publishes Again in Nature Medicine

By Mourabit Halima 2025.05.12

On April 10, 2025, a research team led by Professor Li Zhang and Professor Wenfeng Fang from Sun Yat-sen University Cancer Center published a significant study in the world-renowned journal…

Mok Talk | Lung Cancer Leadership, Innovation, and the Power of Collaboration

By Peng Longmei 2025.05.09

In this special episode of Mok Talk, Professor Tony Mok (The Chinese University of Hong Kong) sits down with three rising oncology experts Professor Yang Xia (Zhejiang University), Professor Wenhua…

Temocillin in the Spotlight: Dr. Francesco Cogliati Dezza on Tackling Antimicrobial Resistance

By Mourabit Halima 2025.05.09

At ESCMID Global 2025, Infectious Disease Frontier sat down with Dr. Francesco Cogliati Dezza to discuss the renewed clinical relevance of temocillin. As resistance to broad-spectrum antibiotics continues to rise,…

Advancing the Diagnosis and Prevention of Congenital CMV: Insights from Dr. Marianne Leruez-Ville

By Mourabit Halima 2025.05.08

At ESCMID Global 2025, one of the world’s leading forums for infectious disease and clinical microbiology, congenital cytomegalovirus (CMV) took center stage as experts explored new avenues in screening, prevention,…

Temocillin and the Search for Carbapenem Alternatives: A Conversation with Dr. Francesco Cogliati Dezza at ESCMID Global 2025

By Peng Longmei 2025.05.08

At ESCMID Global 2025, antimicrobial resistance stood out as one of the most pressing topics. As carbapenem resistance rises to alarming levels worldwide, the medical community is urgently seeking viable…

Prof. Lin Visits MGH | Talk with Prof. Lori Wirth on Targeted Therapy for Advanced Thyroid Cancer

By Mourabit Halima 2025.05.08

Join us for an exclusive conversation between Prof. Yansong Lin of Peking Union Medical College Hospital and Prof. Lori Wirth at Massachusetts General Hospital. In this special academic exchange, the…

Redefining Standards in Urothelial Cancer: A Conversation with Dr. Thomas Powles

By Mourabit Halima 2025.05.08

In this exclusive UroStream interview, we had the privilege of speaking with Dr. Thomas Powles, MD, a leading oncologist at Barts Health NHS Trust and the global lead investigator of…

“50 Years of Hematopoietic Stem Cell Transplantation”

By Mourabit Halima 2025.05.08

We were honored to hear from Professor Xiaojun Huang of Peking University People’s Hospital and the Peking University Institute of Hematology, who shared a comprehensive reflection on the global evolution of hematopoietic stem cell transplantation (HSCT). From Dr. Edward Donnall Thomas' foundational work to the creation of the Beijing Protocol, Professor Huang spotlighted how China’s innovations—including non–T-cell-depleted haploidentical transplantation—are transforming clinical practice worldwide.